10 machine-learning "https:" "https:" "https:" "https:" "https:" "University of St" "St" uni jobs at Center for Biologics Evaluation and Research (CBER)

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 14 days ago

Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing

FDA Research Opportunity - Immune Responses to Influenza Vaccines

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 13 days ago

multiple techniques including multiplex assays, virus neutralization, Plasmon Surface Resonance machines, protein production, and more Learn skills in data analysis software including statistical software

FDA Tick-Borne Pathogen Research Program

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 19 hours ago

humans. Learning Objectives: Under the guidance of a mentor, you will have the opportunity to: Learn fundaments in research in infectious diseases and molecular and immunological methodologies. Obtain

FDA Focus Towards More Efficient Factor VIII Drug Products to Improve the Treatment of Hemophilia A

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 11 days ago

), particularly the respective molecular interactions, and will learn various methodologies to model and test these interactions in vitro. Learning Objectives: Under the guidance of the mentor, you will learn

FDA Evaluation of Platelets: Antimicrobial Treatments and Evaluation of the Treated Products for Functions

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 14 days ago

on the functions of the blood components such as platelets etc. Development of functional quality biomarkers for blood components such as platelets Learning Objectives: By the end of this training opportunity, you

FDA Studies on the Safety and Efficacy of Plasma-Derived Products and Their Recombinant Analogs

Center for Biologics Evaluation and Research (CBER) | United States | about 19 hours ago

that make unwanted antibodies Determine the effect of cognate antigens on immune globulin pharmacokinetics Learning Objectives: Under the guidance of a mentor, you will learn the following laboratory skills

FDA Research Opportunity - Detection of Emerging Pathogens that Threaten Blood Safety

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 13 days ago

safety while improving availability. Learning Objectives: You will learn principles of blood safety and methods for detecting emerging and re-emerging bloodborne viruses. You will use multidisciplinary

FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 20 days ago

for diverse career options after the training period. Flexibility and a willingness to learn new techniques is a desirable quality in the applicant. An allowance for training and/or scientific conference

FDA Research Opportunity in Developing Methods for Efficient Gene Editing in Hematopoietic Stem Cells (HSCs)

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 14 days ago

. Learning Objectives: Under the guidance of a mentor, you will: Develop proficiency in designing, executing, and validating CRISPR/Cas9-mediated genetic modifications in HSCs and other relevant cell types

FDA Evaluation and Characterization of Neutralizing Antibodies Against Viruses Relevant to Blood-Derived Products

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 14 days ago

-derived immunoglobulins coincide with clinically observed escape mutations. J Med Virol. 94, 649-658 (2022). Learning Objectives: This opportunity offers training in cutting edge technologies directly